Orexigen Therapeutics

Orexigen’s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference.

Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
2002
Size (employees)
67 (est)
Orexigen Therapeutics was founded in 2002 and is headquartered in San Diego, US

Orexigen Therapeutics Office Locations

Orexigen Therapeutics has office in San Diego
San Diego, US

Orexigen Therapeutics Metrics

Orexigen Therapeutics Summary

Market capitalization

$59.7 m

Closing share price

$4.2
Orexigen Therapeutics's current market capitalization is $59.7 m.

Orexigen Therapeutics Financials

Orexigen Therapeutics's revenue is $24.5 m in FY, 2015 which is a 55.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$3.4 m$55.5 m$24.5 m

Revenue growth, %

1519.6%(55.9%)

Operating expense total

$80.6 m$86.1 m$84.5 m

EBIT

($77.2 m)($30.5 m)($60.1 m)

Net Income

($77.7 m)($37.5 m)($68.7 m)

Operating cash flow

$19.8 m$6.1 m$51.2 m

Orexigen Therapeutics Market Value History

We estimate that Orexigen Therapeutics's current employees are approximately 20% female and 80% male.

Orexigen Therapeutics Company Life

You may also be interested in